Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1671-1677

  Akaogi, Kotaro ^a   Sato, Junji ^a,b   Okabe, Yukie ^a   Sakamoto, Yoshimasa ^a   Yasumitsu, Hidetaro ^a   Miyazaki, Kaoru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b EIKEN CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; HEPARIN; INSULIN; SECRETORY PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL STRAIN 3T3; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; MITOGENESIS; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; WOUND HEALING;

3T3 CELLS; ANIMALS; CELL ADHESION; CELL DIVISION; CROSS-LINKING REAGENTS; DRUG SYNERGISM; FIBRINOLYTIC AGENTS; HEPARIN; HYPOGLYCEMIC AGENTS; INSULIN; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SOMATOMEDINS;

ANIMALIA;

EID: 0029805003     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Rosen, O. M. After insulin binds. Science (Washington DC), 273: 1452- 1458, 1987.
2. Larner, J. Insulin-signaling mechanisms. Diabetes, 37: 262-275, 1988.
3. Ooi,G.T. Insulin-like growth factor-binding proteins (IGFBPs): more than just 1, 2, 3. Mol. Cell. Endocrinol., 71: c39-c43, 1990.
4. Baxter, R. C., and Martin, J. L. Binding proteins for the insulin-like growth factors: structure, regulation and function. In: J. K. Health (ed.), Progress in Growth Factor Research, Vol. 1, pp. 49-68. London: Pergamon Press, 1989.
5. Kiefer, M. C., Masiarz, F. R., Bauer, D. M., and Zapf, J. Identification and molecular cloning of two new 30 kDa insulin-like growth factor binding proteins (IGFBP) isolated from adult human serum. J. Biol. Chem., 266: 9043-9049, 1991.
6. Kiefer, M. C., Joh, R. S., Bauer, D. M., and Zapf, J. Molecular cloning of a new human insulin-like growth factor binding protein (IGFBP). Biochem. Biophys. Res. Commun., 176: 219-225, 1991.
7. Shimasaki, S., Uchiyama, F., Shimonaka, M., and Ling, N. Molecular cloning of the cDNAs encoding a novel insulin-like growth factor binding protein from rat and human. Mol. Endocrinol., 4: 1451-1458, 1990.
8. Mellow, D., and Baxter, R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I- stimulated DMA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun., 156: 199-204, 1988.
9. Elgin, R. G., Busby, W. H., and Clemmons, D. R. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA, 84: 3254-3258, 1987.
10. Conover, C. A., Ronk, M., Lombana, F., and Powell, D. R. Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology, 127: 2795-2803, 1990.
11. Andress, D. L., and Birnbaum, R. S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem., 267: 22467-22472, 1992.
12. Chen, J. C., Shao, Z. M., Sheikh, M. S., Hussain, A., LeRoith, D., Roberts, C. T., and Fontana, J. A. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. Cell Physiol., 158: 69-78, 1994.
13. Huhtala, M. L., Koistinen, R., Palomaki, P., Partanen, P., Bohn, H., and Seppala, M. Biologically active domain in somatomedin-binding protein. Biochem. Biophys. Res. Commun., 141: 263-270, 1986.
14. Akaogi, K., Okabe, Y., Funahashi, K., Yoshitake, Y., Nishikawa, K., Yasumitsu, H., Umeda, M., and Miyazaki, K. Cell adhesion activity of a 30 kDa major secreted protein from human bladder carcinoma cells. Biochem. Biophys. Res. Commun., 198: 1046-1053, 1994.
15. Murphy, M., Pykett, M. J., Hamish, P., Zang, K. D., and George, D. L. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth & Differ., 4: 715-722, 1993.
16. Swisshelm, K., Ryan, K., Tsuchiya, K., and Sager, R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA, 92: 4472-4476, 1995.
17. Yamauchi, T., Umeda, F., Masakado, M., Isaji, M., Mizushima, S., and Nawata, H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem. J., 303: 591-598, 1994.
18. Akaogi, K., Okabe, Y., Sato, J., Nagashima, Y., Yasumitsu, H., Sugahara, K., and Miyazaki, K. Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc. Natl. Acad.Sci. USA, 93: 8384-8389, 1996.
19. Clemmons, D. R., Elgin, R. G., Han, V. K. M., Casella, S. J., D'Ercole, A. J., and Van Wyk, J. J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor-I. J. Clin. Invest., 77: 1548-1556, 1986.
20. Kiefer, M. C., Schmid, C., Waldvogel, M., Schläpfer, I., Futo, E., Masiarz, F. R., Green, K., Barr, P. J., and Zapf, J. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J. Biol. Chem., 267: 12692-12699, 1992.
21. Klarlund, J. K., and Czech, M. P. Insulin-like growth factor I and insulin rapidly increase casein kinase II activity in BALB/c3T3 fibroblasts. J. Biol. Chem., 263: 15872-15875, 1988.
22. Clemmons, D. R., Van Wyk, J. J., and Pledger, W. J. Sequential addition of platelet factor and plasma to BALB/c3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle. Proc. Natl. Acad. Sci. USA, 77: 6644-6648, 1980.
23. Wang, J. F., Hampton, B. Mehlman, T., Burgess, W. H., Rechter, M. M. Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. Biochem. Biophys. Res. Commun., 157: 718-726, 1988.
24. Ritvos, O., Ranta, T., Jalkanen, J., Suikkari, A. M., Voutilainen, R., Bohn, H., and Rutanen, E. M. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology, 122: 2150-2157, 1988.
25. Jones, J. I., Gockerman, A., Busby, W. H., Jr., Camacho-Hubner, C., and clemmons, D. R. Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol., 121: 679-687, 1993.
26. Conover, C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology, 130: 3191-3199, 1992.
27. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
28. McConahey, P. J., and Dixon, F. J. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol., 70: 210-213, 1980.